Skip to main content
Skip to content
Case File
efta-01449662DOJ Data Set 10Other

EFTA01449662

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01449662
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
SOUTHERN FINANCIAL, 1.I.0 ACCT. For the Period 8/1/13 to S/31/13 Note Unrealized Gain Loss is shown as "N. A" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan learn (or additional information. Equity Detail Price Quantity Value Adjusted Cost Original Cost Unrealized GalnA.oss Est. Annual Inc. Accruec —liW7 Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 04033A-10-0 ARIA 18.60 16.535 000 307,551.00 290,997.40 16,553.60 BIOGEN IDEC INC 09062X-104 BNB 213.02 2,099.000 448,276.90 250,454.95 199,821.95 FACEBOOK 1NC-A 30303M-10-2 FB 41.29 17,500.000 722,645.00 665,000.00 67,645.00 GENERAL ELECTRIC CO 369604-10-3 GE 23.14 23,000.000 532,220.00 496,109.06 36,110.92 17,480.00 3.28% JPM VALUE ADVANTAGE FD -INSIL FUND 1400 4812A2-58-7 JVAI X 24.96 78,709.170 1.964.580.88 2,000,000.00 (35,419.12) 19,992.12 1.02% Total US Large Cap Equity US Small/Mid Cap Equity DEUTSCHE 8K AG LDN BRH DBL LONG ETN38 25154H-55-8 DAG 8.90 50,000.000 53,973,273.78 445800 00 53,702,561.43 352.529.00 $270,712.36 92,471.00 937,472.12 0.94% J.P Morgan Accounnage 5 of 48 Consolidated Statement Page 8 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 105116 CONFIDENTIAL SDNY_GM_00251300 EFTA01449662

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.